Kopin Corporation — FY2013 Form 10-K
Reporting period: Fiscal year ended December 28, 2013 (52 weeks). The filing is an annual report, not a standalone fourth-quarter filing; it also provides unaudited Q4 results. In January 2013, Kopin sold its III-V product line, and prior-period results were recast to show that business as discontinued operations.
Business context
Kopin develops miniature display products and wearable-computing technologies, including headset reference designs such as Golden-i. After selling the III-V product line, its continuing business focused on displays, wearable technology, and reflective displays through subsidiary Forth Dimension Displays (FDD). Wearable licensing revenue remained de minimis in 2013.
Financial performance and liquidity
| Metric | FY2013 | FY2012 |
|---|---|---|
| Continuing-operations revenue | $22.9 million | $34.6 million |
| Net product revenue | $20.6 million | $31.3 million |
| Research and development revenue | $2.3 million | $3.3 million |
| Operating loss | $35.9 million | $20.6 million |
| Loss from continuing operations | $25.8 million | $21.8 million |
| Net loss | $5.6 million | $19.0 million |
| Operating cash flow | $(18.9) million | $3.8 million |
| Cash, equivalents and marketable debt securities | $112.7 million | $92.5 million |
| Working capital | $108.4 million | $106.8 million |
| Long-term obligations | $0.3 million | $0.9 million |
Product cost of $20.7 million exceeded product revenue of $20.6 million, producing a gross loss of about $0.1 million (gross margin approximately negative 0.4%). The operating loss widened as revenue declined and internal R&D and SG&A increased. The net loss includes $20.1 million of after-tax income from discontinued operations, principally the sale gain; continuing operations remained loss-making. The filing reports no material conventional debt balance; long-term obligations shown are primarily asset-retirement obligations.
Operating cash use was $18.9 million. Year-end cash and equivalents were $16.8 million, with $96.0 million of marketable debt securities. Working capital was $108.4 million. The balance sheet also included a $14.9 million note receivable for the III-V sale, due in 2016; it is collateralized, but repayment is subject to the buyer meeting debt-compliance conditions. The company repurchased $8.0 million of its stock and spent $0.7 million on capital expenditures during 2013.
For Q4 FY2013, revenue was $5.55 million, gross profit was $0.65 million, loss from continuing operations was $9.84 million, and net loss attributable to the controlling interest was $9.66 million. The quarter included impairment and investment write-offs.
Material changes versus prior periods
- Revenue from continuing operations declined 34% year over year. Military application sales fell to $8.6 million from $19.6 million, while consumer-electronics sales also declined. Management attributed the military reduction chiefly to lower U.S. government demand.
- Military customers represented 38% of total revenue in 2013, down from 57% in 2012. U.S. government-funded R&D revenue fell to $2.3 million from $3.3 million.
- Internal R&D expense rose to $16.0 million from $12.1 million, largely reflecting wearable product and software development. SG&A increased to $19.1 million from $17.2 million.
- Cost of product revenue was 100.4% of product revenue, versus 70.3% in 2012, as lower military volume and product mix reduced margins and raised fixed cost per unit.
- The III-V sale generated a final purchase price of $70.2 million. Kopin received $55.2 million in 2013; approximately $15 million remains payable in 2016. The reported after-tax sale gain was approximately $20.1 million.
- Kopin recorded $5.0 million of impairment charges on minority investments and $1.5 million of intangible-asset impairment. Ask Ziggy’s investment was written down to zero. Kowon manufacturing operations ceased, and Kopin increased its ownership in Kowon to 93%.
Outlook, risks and contingencies
Management forecast FY2014 revenue of $18–$22 million and a consolidated net loss of $32–$40 million. It expected operating cash usage of $30–$35 million, excluding working-capital effects, stock buybacks, and other investing activities, and capital expenditures of $2–$3 million. Management cautioned that losses could exceed its estimate and emphasized product development and customer relationships over near-term financial targets. It believed available cash resources would fund operations and capital needs for at least 12 months.
- Wearable products were still at an early commercialization stage; adoption, comfort, software integration, licensing, and customer demand were uncertain, and 2014 development and marketing costs were expected to be significant.
- Revenue and cash flow remained exposed to U.S. military budget reductions, contract delays or termination, and qualification outcomes for new weapon-sight programs. Management expected design work through much of 2014 and only limited orders potentially in 2015.
- Revenue concentration, short-term and cancelable customer orders, and a limited customer backlog make forecasting difficult. The company also depends on a small number of foundries and suppliers for critical components.
- Other disclosed risks include competition from substantially larger companies, foreign-exchange exposure without hedging, intellectual-property and software licensing risks, and environmental, export-control, government-contracting, and conflict-minerals compliance obligations.
- The company had $7.35 million of operating lease commitments and described legal proceedings only as matters arising in the ordinary course; the filing does not provide a clear quantified litigation contingency.
Most important facts for investors to verify
- Whether the remaining approximately $15 million III-V sale payment is collected when due, given the buyer’s debt-compliance condition.
- Whether FY2014 revenue, net-loss, and cash-use guidance is achieved, and how much cash is consumed by operations and investments.
- Whether wearable products secure meaningful customers, licensing revenue, and repeat component sales after 2013 de minimis licensing revenue.
- Whether military demand and margins stabilize, and whether new weapon-sight designs are selected and funded.
- Whether the company’s investment impairments, subsidiary losses, and supplier dependencies result in further charges or operating disruptions.